Cite

    Liu, Y. et al. (n.d.). A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor‐β and vascular endothelial growth factor signalling. Liver international. pp. 504-515. [Online].